Veritable, L.P. Novavax Inc Transaction History

Veritable, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$69.73 - $142.9 $102,991 - $211,063	-1,477 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$134.56 - $217.97 $27,181 - $44,029	-202 Reduced 12.03%	1,477 $211,000
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $33,782 - $51,410	190 Added 12.76%	1,679 $348,000
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $4,598 - $9,791	38 Added 2.62%	1,489 $316,000
Q1 2021 May 17, 2021	BUY	$112.98 - $319.93 $163,933 - $464,218	1,451 New	1,451 $263,000

286

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $713M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.